Condition:   Myasthenia Gravis
Interventions:   Drug: Placebo;   Drug: 250 mg CK-2017357;   Drug: 500 mg CK-2017357
Sponsors:   Cytokinetics;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified August 2011